Catheter Precision, Inc. Other Comprehensive Income (Loss), Net of Tax
Catheter Precision, Inc. (VTAK) reported Other Comprehensive Income (Loss), Net of Tax of -$26.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-24.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2022-03-24
- Catheter Precision, Inc. other comprehensive income (loss), net of tax for the quarter ending 2020-12-31 was $0.00.
- Catheter Precision, Inc. other comprehensive income (loss), net of tax for the quarter ending 2020-09-30 was $0.00.
- Catheter Precision, Inc. other comprehensive income (loss), net of tax for the quarter ending 2020-06-30 was -$4.00K, a 107.84% decline year-over-year.
- Catheter Precision, Inc. other comprehensive income (loss), net of tax for the quarter ending 2020-03-31 was -$22.00K.
- Catheter Precision, Inc. other comprehensive income (loss), net of tax for fiscal 2020 was -$26.00K, a 200.00% decline from fiscal 2019.
- Catheter Precision, Inc. other comprehensive income (loss), net of tax for fiscal 2019 was $26.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | -$4.00K derived: sum of 3 quarters · filed 2022-03-24 | -$26.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$4.00K derived: sum of 2 quarters · filed 2021-11-15 | -$26.00K 10-Q · filed 2020-11-16 | -$38.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$4.00K 10-Q · filed 2021-11-15 | -$26.00K 10-Q · filed 2021-08-11 | -$38.00K derived: sum of 3 quarters · filed 2021-11-15 | -$51.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-03-31 | -$22.00K 10-Q · filed 2021-11-15 | -$34.00K derived: sum of 2 quarters · filed 2021-11-15 | -$47.00K derived: sum of 3 quarters · filed 2021-11-15 | $4.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2019-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$25.00K derived: sum of 2 quarters · filed 2021-03-17 | $26.00K derived: sum of 3 quarters · filed 2021-03-17 | $26.00K 10-K · filed 2021-03-17 |
| 2019-09-30 | -$13.00K 10-Q · filed 2020-11-16 | $38.00K derived: sum of 2 quarters · filed 2020-11-16 | $38.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $51.00K 10-Q · filed 2020-11-16 | $51.00K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |